Roivant spinoff Datavant is joining forces with medical data technology peer Ciox Health, which counts Merck & Co as an investor.

Two US-based, corporate backed companies – medical data exchange Datavant and healthcare data software provider Ciox Health – agreed to a merger yesterday valuing the joint business at $7bn. Launched by biopharmaceutical company builder Roivant Sciences in 2017, Datavant provides software which helps businesses manage privacy, security and compliance for medical data repositories while sharing…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.